Medplus Health Services per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹17.64₹18.33₹12.57₹5.48₹4.17
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹17.62₹18.29₹12.52₹5.45₹4.17
₹164.54₹164.54₹145.42₹132.01₹124.99
₹631.98₹574.11₹512.64₹470.56₹382.01
—₹41.28₹45.15₹12.02₹7.58
₹31.03₹31.03₹40.18₹4.96−₹6.59
12.012.012.012.011.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MEDPLUS₹595.00

Medplus Health Services Ltd.

· Consumer Services
₹ CrorePeersAPOLLOHOSPMANYAVARMSTCLTDNESCOJUSTDIALJSLLQUESSIXIGOMcap ₹7,143 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS4.175.4812.5718.3317.64
Diluted EPS4.175.4512.5218.2917.62
Book Value per Share124.99132.01145.42164.54164.54
Revenue per Share382.01470.56512.64574.11631.98
Cash Flow per Share7.5812.0245.1541.28—
Free Cash Flow per Share-6.594.9640.1831.0331.03
Shares Outstanding (cr)11.912.012.012.012.0
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.